| (AUD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 21.30M | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, BLS.AX returned +70.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +119.0% |
| 1 year | +70.4% |
| 5 years | +178.8% |
| 10 years | +497.4% |
| All-time high | $131.23 (May 2002) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in BLS.AX would be worth today ›No. BLS Pharmaceuticals Limited has not paid a dividend in the past 12 months.
BLS Pharmaceuticals Limited is part of the Healthcare sector.
BLS Pharmaceuticals Limited has a market cap of 211.88M AUD, based on the latest quote.
